We can’t wait for our future with Digital Diagnostics! We’re taking a moment to reflect on these last eight years. Check out our CEO's (@liz_asai) thoughts on the acquisition. https://t.co/XXL0poWreQ
Exciting news: We’ve been acquired by Digital Diagnostics! We feel so fortunate to be joining an incredible and brilliant team with a shared mission to increase patients' access to healthcare with #telemedicine and #autonomousAI. Read more: https://t.co/0tq5zjze4y
Major news: @CMSGov's proposed 2021 #PFS incl. first-ever coverage for #AutonomousAI diagnostic systems. 9225x reimburses PCPs using #AI to interpret retinal images. A historic precedent for the entire #healthcareAI community and many innovations to come https://t.co/2vRILkw20c
Excited to share 3Derm ImageAssist, a new resource for dermatologists that helps patients take good telederm photos from home! It’s free for any clinics affected by COVID-19. @AADmember can check it out in the AAD Telederm Toolkit here: https://t.co/3zMbdcSPfB
#MondayMotivation read to start your week.
Kudos to @3Derm on its recent announcement of two @US_FDA Breakthrough Device designation for its autonomous skin cancer #AI.
🔗 https://t.co/xzO8WGa69N
.@JenaValve's tech is being designed for patients with severe aortic regurgitation and AR-dominant mixed aortic valve disease at high risk for surgery.
Other recent breakthrough device-winning firms include @3Derm, KDx Diagnostics and @reflowmedical.
https://t.co/OqNTMPmvBM
“We’ve taken a different approach to skin cancer AI. Our systems are “autonomous”, meaning our algorithm outputs a yes/no response that needs no clinical interpretation and can be evaluated in clinical trials like any other screening test.” CEO @liz_asai https://t.co/R3DQaCXC6U
The #FDA has granted #Breakthrough Status to our autonomous skin cancer #AI. We’re excited to continue collaborating with the Agency to bring these algorithms to patients and providers and transform access to #dermatology. Learn more here. #autonomousAI
https://t.co/NyJD0pYDIt
Thanks to all who attended our #telemedicine demonstration at the State House today. We enjoyed sharing the power tMed is poised to have in Massachusetts, including students and those living in rural areas.
Thanks for the shoutout! Working with innovative leaders like @HarvardPilgrim creates new opportunities to help patients access critical care in a timely and cost-effective way. We look forward to continuing this partnership!